XBIO Xenetic Biosciences Inc
Company Analysis
Latest News
🟢 Xenetic Biosciences is trading 11.4% up today following proposed all-stock Santersus acquisition
Xenetic Biosciences is trading 11.4% up at $2.74 amid continued volatility following its proposed all-stock acquisition of Santersus AG. - Santersus...
🟢 Xenetic Biosciences is trading 6.5% up today following proposed all-stock acquisition
Xenetic Biosciences is trading 6.5% up now at $2.62 amid continued volatility following its proposed all-stock acquisition of Santersus AG. - Santersus...
🔴 Xenetic Biosciences is trading 6.4% down today as Santersus shareholders would own 85%
Xenetic Biosciences is trading 6.4% down now at $2.30 as investors continue repricing the proposed all-stock acquisition of Santersus AG. - Under the...
🔴 Xenetic Biosciences is trading 6.1% down in pre-market over dilution concerns tied to proposed Santersus acquisition
Xenetic Biosciences is trading 6.1% down now at $2.31 as investors continue weighing the proposed all-stock acquisition of Santersus AG. - Santersus...
🟢 Xenetic Biosciences is trading 8.5% up today in pre-market amid stronger overnight equity sentiment
Xenetic Biosciences is trading 8.54% up at $2.67, with the rebound broadly supported by stronger overnight equity sentiment after closing September 17, 2026,...
🔴 Xenetic Biosciences is trading 5.49% down in after-hours trading with no identified company announcement
Xenetic Biosciences is trading 5.49% down at $2.33 after no separate company announcement dated September 17 was identified to explain the after-hours...
🟢 Xenetic Biosciences is trading 11% up today as biotech shares rally
Xenetic Biosciences is trading 11.03% up now at $2.43 as biotechnology shares rally alongside broader risk-on markets. - The sector’s advance reflects...
🟢 Xenetic Biosciences rises 5.9% — Biotech Sector Rallies on Strong Industry Outlook and M&A Optimism
With Biotech (XBI) up 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector, as measured by the XBI ETF,...
🔴 Xenetic Biosciences is trading 5.94% down in pre-market over dilution concerns from proposed Santersus deal
Xenetic Biosciences is trading 5.94% down at $2.06 after its September 16, 2026 announcement of a proposed all-stock acquisition of Santersus AG. - Existing...
🔴 Xenetic Biosciences is trading 38.76% down today after announcing proposed all-stock acquisition of Santersus AG
Xenetic Biosciences is trading $2.62 (-38.76%) after announcing a proposed all-stock acquisition of Santersus AG. - The transaction was announced on September...
XBIO Hands 85% of Itself to a Swiss Blood-Cleaning Startup — Is the Remaining Sliver Worth the Gamble?
Shares of Xenetic Biosciences (XBIO) cratered 22% to $3.32 on September 16 after the micro-cap biotech disclosed a reverse merger with Santersus AG, a private...
🔴 Xenetic Biosciences is trading 22.17% down in pre-market after announcing all-stock reverse merger with Santersus AG
Xenetic Biosciences is trading at $3.32, down 22.17%, in pre-market after announcing an all-stock reverse merger with Santersus AG on September 16, 2026. •...
Xenetic Biosciences to Acquire Santersus AG in All-Stock Reverse Merger Transaction
Xenetic Biosciences, Inc. (XBIO) has entered into a Share Exchange Agreement to acquire Santersus AG, a Swiss corporation. The all-stock transaction will...
🔴 Xenetic Biosciences falls 5.6% — Biotech Sector Declines on Key Drug Trial Failure and Shifting Investor Sentiment
With Biotech (XBI) down 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, as measured by the XBI ETF, fell...
🟢 Xenetic Biosciences is trading 5.9% up today with no confirmed catalyst
Xenetic Biosciences is trading 5.9% up at $4.13, with no confirmed company-specific catalyst identified. - No new company-specific announcement or filing...
🔴 Xenetic Biosciences is trading 5.16% down today with no confirmed catalyst identified
Xenetic Biosciences is trading at $3.86 (-5.16%), with no clear company-specific announcement identified for September 11, 2026. - The company’s latest listed...
🔴 Xenetic Biosciences is trading 5.4% down in after-hours trading as hotter producer inflation pressures markets
Xenetic Biosciences is trading 5.4% down at $3.85 after closing at $4.07 on September 10, 2026, amid weaker market sentiment following hotter producer...
🔴 Xenetic Biosciences is trading 10.49% down today as U.S. markets reopen under pressure
Xenetic Biosciences is trading 10.49% down now at $4.18, primarily amid broad risk-off sentiment, with no company-specific catalyst identified for September 8,...
🔴 Xenetic Biosciences is trading 7.82% down today amid broad market weakness with no company-specific catalyst identified
Xenetic Biosciences is trading 7.82% down at $4.30 after no new company-specific catalyst was identified in September 8, 2026 coverage. - U.S. markets reopened...
🟢 Xenetic Biosciences is trading 5.92% up today amid strong biotech sector momentum
Xenetic Biosciences is trading at $4.90, up 5.92%, amid strong biotech risk-on momentum. - No new company-specific announcement or SEC filing was identified...